Precise probes of type II interferon activity define the origin of interferon signatures in target tissues in rheumatic diseases.
about
Recent advances in primary Sjogren's syndromeThe clinical relevance of animal models in Sjögren's syndrome: the interferon signature from mouse to manChildhood Sjögren syndrome: insights from adults and animal modelsType I interferon in the pathogenesis of lupus.Modular transcriptional repertoire analyses of adults with systemic lupus erythematosus reveal distinct type I and type II interferon signatures.Lymphotoxin-LIGHT pathway regulates the interferon signature in rheumatoid arthritis.NCR3/NKp30 contributes to pathogenesis in primary Sjogren's syndrome.Molecular Subsetting of Interferon Pathways in Sjögren's Syndrome.Low numbers of blood and salivary natural killer cells are associated with a better response to belimumab in primary Sjögren's syndrome: results of the BELISS studyType I and II interferon signatures in Sjogren's syndrome pathogenesis: Contributions in distinct clinical phenotypes and Sjogren's related lymphomagenesis.Development of Th17-Associated Interstitial Kidney Inflammation in Lupus-Prone Mice Lacking the Gene Encoding STAT-1.Overlap between differentially methylated DNA regions in blood B lymphocytes and genetic at-risk loci in primary Sjögren's syndromeBlockade of interferon-γ normalizes interferon-regulated gene expression and serum CXCL10 levels in patients with systemic lupus erythematosus.Interferon-γ and systemic autoimmunity.Advances in understanding the role of type I interferons in systemic lupus erythematosus.Endoplasmic reticulum stress causes autophagy and apoptosis leading to cellular redistribution of the autoantigens Ro/Sjögren's syndrome-related antigen A (SSA) and La/SSB in salivary gland epithelial cells.Understanding Human Autoimmunity and Autoinflammation Through Transcriptomics.Innate immunity in Sjögren's syndrome.A re-evaluation of anti-NA-14 antibodies in patients with primary Sjögren's syndrome: Significant role of interferon-γ in the production of autoantibodies against NA-14.Upregulation of long noncoding RNA TMEVPG1 enhances T helper type 1 cell response in patients with Sjögren syndrome.Enrichment of Scleroderma Vascular Disease-Associated Autoantigens in Endothelial Lineage Cells.Single-cell analysis reveals sexually dimorphic repertoires of Interferon-γ and IL-17A producing T cells in salivary glands of Sjögren's syndrome miceManagement of primary Sjögren's syndrome: recent developments and new classification criteria.Fatigue in Primary Sjögren's Syndrome: Clinical, Laboratory, Psychometric, and Biologic Associations.Cepharanthine Inhibits IFN-γ-Induced CXCL10 by Suppressing the JAK2/STAT1 Signal Pathway in Human Salivary Gland Ductal Cells.Association of Increased Treg Cell Levels With Elevated Indoleamine 2,3-Dioxygenase Activity and an Imbalanced Kynurenine Pathway in Interferon-Positive Primary Sjögren's Syndrome.Expression of type III interferons (IFNλs) and their receptor in Sjögren's syndrome.Plasmacytoid dendritic cells control dengue and Chikungunya virus infections via IRF7-regulated interferon responses.Sjögren syndromeIFI16 filament formation in salivary epithelial cells shapes the anti-IFI16 immune response in Sjögren's syndrome
P2860
Q26747049-9CC05E3D-966C-42AF-9896-7E3C2A6ABADEQ26825196-60EF2C98-3D99-4F4A-A9BF-6C80B2B4A0E8Q33724868-9E887A82-B484-46C2-9B89-456D4331D697Q33852174-69983159-54B3-475D-B3D1-6A0E8DAEEC2DQ34149941-BFD059F5-909A-411E-89DA-6844B1E3AFF9Q34535634-5D6D325E-4805-4EB3-966A-453DFE50DA48Q34541173-250FEF16-7183-4BF2-98BF-2FDA28520953Q36001863-FA11BBE1-3851-42C1-93D4-58B62649E8AAQ36027561-AEAE1132-CF8F-4C4D-9EB2-0EB663826C92Q36042432-E1FAD9DC-0E27-439D-A385-C16EA42123BFQ36844749-9682C3E4-91CB-4A42-9E78-4168892BE894Q36859599-C9F3468A-F34C-40EE-A3E9-BE53BED2AE54Q37320550-73AD2718-27E2-4A72-B164-7F0AA6B09A6EQ37603372-E49C579F-E1C0-4CD4-90A3-560397D29511Q38227972-EB62374D-2422-4BEB-945E-2B078594CF88Q38890572-1EDA63A1-1E7E-42C6-85C5-D202767C4451Q38988559-81EED529-D240-468C-97CF-ADECD67A76D7Q39232871-234E78DA-1468-4E00-8635-8E5D84D5F091Q39666749-49F9B5D2-4513-498E-B25D-AA37EF95941CQ40462144-02EF40ED-09F7-4214-92E5-8284AB53B8CBQ41633177-419CF6D2-AB53-4070-94F3-DAE7EE867109Q41991901-851A0AEC-9665-4B2F-B1D7-FC2E33BB2A1FQ47700923-DA8713DC-AF52-4788-B68B-F1124C538F07Q47942672-6ABF240B-9C59-4A47-A243-31CE0248C582Q48114706-0991F372-BF1F-4ADC-AA26-2361F653C43BQ50670959-8560FB21-E5C0-4938-8F9A-7D68BB0EFA17Q51524101-A3380F19-9986-463B-9E33-D971ECEE4989Q55278680-A6E27D9D-42B8-4011-A9BD-8C8B4B50A2A0Q55970262-405ECE7D-D3A8-4CA8-80ED-AE13D8E5BCB3Q59125538-8F5D54EB-5729-47EE-9DD3-98F36AAD0088
P2860
Precise probes of type II interferon activity define the origin of interferon signatures in target tissues in rheumatic diseases.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Precise probes of type II inte ...... tissues in rheumatic diseases.
@ast
Precise probes of type II inte ...... tissues in rheumatic diseases.
@en
type
label
Precise probes of type II inte ...... tissues in rheumatic diseases.
@ast
Precise probes of type II inte ...... tissues in rheumatic diseases.
@en
prefLabel
Precise probes of type II inte ...... tissues in rheumatic diseases.
@ast
Precise probes of type II inte ...... tissues in rheumatic diseases.
@en
P2093
P2860
P356
P1476
Precise probes of type II inte ...... tissues in rheumatic diseases.
@en
P2093
Alan E Berger
Alan N Baer
Antony Rosen
Athanasios G Tzioufas
Chris Cheadle
Efstathia K Kapsogeorgou
John C Hall
Livia Casciola-Rosen
P2860
P304
17609-17614
P356
10.1073/PNAS.1209724109
P407
P577
2012-10-08T00:00:00Z